RAPT - RAPT Therapeutics Inc
58.02
0.040 0.069%
Share volume: 11,125,216
Last Updated: 03-02-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$57.98
0.04
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 03-06-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | |
| Cash flow financing | 9.036 M | 701.000 K | 0.000 | 143.115 M | 0.000 | 161.000 K | 36.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -2.161 M | -8.240 M | 0.000 | 131.835 M | -109.478 M | -18.371 M | -3.956 M | |
| Net income | -30.521 M | -27.663 M | -18.432 M | -53.249 M | -17.165 M | -17.643 M | -17.580 M | |
| Depreciation | 314.000 K | 305.000 K | 297.000 K | 287.000 K | 252.000 K | 228.000 K | 205.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 15.887 M | 19.213 M | 18.445 M | -843.000 K | -57.064 M | -7.261 M | 8.466 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 105.000 K | -1.000 K | 17.000 K | 1.000 K | 43.000 K | 40.000 K | 0.000 | |
| Cash Change | -2.161 M | -8.240 M | 823.000 K | 131.835 M | -109.478 M | -18.371 M | -3.956 M |